BMRA Biomerica Inc.
6,512
$0.626
$0.017
(2.64%)
| Watchers | 6,512 |
| 52-Wk Low | $0.50 |
| 52-Wk High | $2.13 |
| Market Cap | $10.53M |
| Volume | 28,140.00 |
| 52-Wk High | $2.13 |
| 52-Wk Low | $0.50 |
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceGlobe Newswire • 2 months ago
Collaborators at the University of Michigan will present new Data on InFoods IBS in the DDW Irritable Bowel Syndrome (IBS) Clinical Session IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE...
Share to Feed
Biomerica, Inc. (NASDAQ:BMRA Get Free Report) saw a large decrease in short interest in March. As of March 15th, there was short interest totalling 76,700 shares, a decrease of 42.5% from the...
Biomerica, Inc. (NASDAQ:BMRA Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.99 and traded as low as $0.84...
Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and healthcareIRVINE, Calif., Feb. 21, 2024...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently served as CEO of Meridian Bioscience where he successfully...
Biomerica, Inc. (NASDAQ:BMRA Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling...
Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of 2023.Loss per shares narrows to $0.09 per share from $0.12 per share...